Viewing Study NCT00964457


Ignite Creation Date: 2025-12-24 @ 6:40 PM
Ignite Modification Date: 2026-01-06 @ 10:08 PM
Study NCT ID: NCT00964457
Status: UNKNOWN
Last Update Posted: 2009-08-25
First Post: 2009-08-21
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: Treatment of Patients With Advanced Rectum Cancer With Capecitabine and Oxaliplatin Before, Under and After Radiation and With Adding Cetuximab to K-RAS Wild-type Patients
Sponsor: Copenhagen University Hospital at Herlev
Organization:

Organization Data

Organization:
Class: OTHER
Study ID: GI0905
Study Type: None
Study Domain: None
Study Link: None
Lead Sponsor:
Lead Sponsor Class: OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type: None
Responsible Party Affiliation:
Old Name: Ole Larsen, MD, Herlev hospital
Old Organization: hospital

Collaborators